Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Yun

Showing results (191-200 of 214) with videos related to

Pageof 22
Sort By:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|December 3, 2003
[Clinical diagnosis, treatment and prognosis of elderly SARS patients]Bin Cao, Zheng-yin Liu, Meng-zhao Wang, et al.
Molecular Cancer Therapeutics|May 29, 2014
Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomasXue-Li Bai, Qi Zhang, Long-Yun Ye, et al.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue = Chinese Critical Care Medicine = Zhongguo Weizhongbing Jijiuyixue|May 2, 2006
[Study on up-regulation of the expression of angiotensin-converting enzyme-2 in human umbilical vein endothelial cells by telmisartan]Li-jun Wang, Hong Ma, Xin-xue Liao, et al.
World Journal of Gastroenterology|September 17, 2013
Acute iatrogenic Budd-Chiari syndrome following hepatectomy for hepatolithiasis: a report of two casesXue-Li Bai, Yi-Wen Chen, Qi Zhang, et al.
Frontiers in Oncology|March 22, 2021
Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 PatientsXin-Yu Ren, Yu Song, Jing Wang, et al.
Cancer Letters|September 27, 2023
Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinomaTian-Jiao Li, Kai-Zhou Jin, Hong-Yu Zhou, et al.
The FEBS Journal|May 28, 2023
Inhibition of epithelial-to-mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinomaKai-Zhou Jin, Ying Wu, Xiao-Xiao Zheng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 19, 2017
Hook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinomaXu Sun, Qi Zhang, Wei Chen, et al.
Computational and Structural Biotechnology Journal|December 11, 2020
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspectiveWu-Hu Zhang, Wen-Quan Wang, Xuan Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland ChinaYi-Long Wu, Wen-Zhao Zhong, Long-Yun Li, et al.
Pageof 22

Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|December 3, 2003
[Clinical diagnosis, treatment and prognosis of elderly SARS patients]Bin Cao, Zheng-yin Liu, Meng-zhao Wang, et al.
Molecular Cancer Therapeutics|May 29, 2014
Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomasXue-Li Bai, Qi Zhang, Long-Yun Ye, et al.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue = Chinese Critical Care Medicine = Zhongguo Weizhongbing Jijiuyixue|May 2, 2006
[Study on up-regulation of the expression of angiotensin-converting enzyme-2 in human umbilical vein endothelial cells by telmisartan]Li-jun Wang, Hong Ma, Xin-xue Liao, et al.
World Journal of Gastroenterology|September 17, 2013
Acute iatrogenic Budd-Chiari syndrome following hepatectomy for hepatolithiasis: a report of two casesXue-Li Bai, Yi-Wen Chen, Qi Zhang, et al.
Frontiers in Oncology|March 22, 2021
Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 PatientsXin-Yu Ren, Yu Song, Jing Wang, et al.
Cancer Letters|September 27, 2023
Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinomaTian-Jiao Li, Kai-Zhou Jin, Hong-Yu Zhou, et al.
The FEBS Journal|May 28, 2023
Inhibition of epithelial-to-mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinomaKai-Zhou Jin, Ying Wu, Xiao-Xiao Zheng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 19, 2017
Hook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinomaXu Sun, Qi Zhang, Wei Chen, et al.
Computational and Structural Biotechnology Journal|December 11, 2020
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspectiveWu-Hu Zhang, Wen-Quan Wang, Xuan Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland ChinaYi-Long Wu, Wen-Zhao Zhong, Long-Yun Li, et al.
Pageof 22